<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04151771</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01641</org_study_id>
    <secondary_id>SNCTP000003509</secondary_id>
    <secondary_id>2019-01641</secondary_id>
    <nct_id>NCT04151771</nct_id>
  </id_info>
  <brief_title>Low-load Blood Flow Restriction Training in COPD</brief_title>
  <acronym>LL-BFRT COPD</acronym>
  <official_title>Low-load Blood Flow Restriction Training in COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Peripheral muscle weakness is a predominant problem in patients with COPD and treated using
      exercise training in pulmonary rehabilitation. Despite pulmonary rehabilitation being an
      effective intervention, muscle strength impairment is a persisting problem in COPD patients.
      Patients have problems to tolerate the high training loads, which are necessary to develop
      strength. Low-load blood flow restriction training (LL-BFRT) might therefore be an option to
      enhance muscular response of patients with COPD to strength training. Up to now, no studies
      investigating LL-BFRT in respiratory diseases are available.

      The primary outcome of this randomized pilot study is knee extensor muscle strength.
      Secondary, the study will evaluate if LL-BFRT is well tolerated and feasible in COPD patients
      attending outpatient pulmonary rehabilitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 27, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee extensor strength</measure>
    <time_frame>during 12 weeks (24 exercise sessions)</time_frame>
    <description>Between-group difference in total change in isometric muscle strength of the knee extensor muscles, measured by handheld dynamometry in newtonmeter</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>COPD</condition>
  <condition>Muscle Weakness</condition>
  <arm_group>
    <arm_group_label>LL-BFRT group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomised into intervention group are attending pulmonary rehabilitation in which strengthening exercises of the lower limb are performed using LL-BFRT.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual pulmonary rehabilitation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomised into control group are attending usual pulmonary rehabilitation as established.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low-load blood flow restriction training</intervention_name>
    <description>The intervention group will perform the exercises of the lower limbs using LL-BFRT with an occlusion pressure of 70% of arterial occlusion pressure with low training loads (30% of the 1 repetition maximum).</description>
    <arm_group_label>LL-BFRT group</arm_group_label>
    <other_name>LL-BFRT</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual outpatient pulmonary rehabilitation</intervention_name>
    <description>The control group will perform outpatient pulmonary rehabilitation as established.</description>
    <arm_group_label>Usual pulmonary rehabilitation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed COPD according to GOLD-guidelines

          -  Assigned to outpatient pulmonary rehabilitation by the treating physician

        Exclusion Criteria:

          -  Physical or intellectual impairment precluding informed consent or protocol adherence

          -  Non-German speaking (precluding informed consent)

          -  Acute or recent (within the last 6 weeks) exacerbation of COPD

          -  Attending a pulmonary rehabilitation program within the last 3 months

          -  Pregnant patients

          -  History of thromboembolic event in the lower extremity

          -  Diagnosis of polyneuropathy

          -  Resting systolic blood pressure &lt;100 mmHg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christian F Clarenbach, MD</last_name>
    <phone>+41 44 255 17 12</phone>
    <email>christian.clarenbach@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian F Clarenbach, MD</last_name>
      <phone>+41 44 255 17 12</phone>
      <email>christian.clarenbach@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Dario Kohlbrenner, MSc</last_name>
      <phone>+41 43 253 08 42</phone>
      <email>dario.kohlbrenner@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>October 31, 2019</study_first_submitted>
  <study_first_submitted_qc>November 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2019</study_first_posted>
  <last_update_submitted>April 24, 2020</last_update_submitted>
  <last_update_submitted_qc>April 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>blood flow restriction training</keyword>
  <keyword>pulmonary rehabilitation</keyword>
  <keyword>COPD</keyword>
  <keyword>muscle weakness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscle Weakness</mesh_term>
    <mesh_term>Paresis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

